REGN News and Press, Regeneron Pharmaceuticals Inc. From 01/03/24

2024-01-03 06:43:17 ET More on Alvotech, Regeneron, etc. Regeneron Pharmaceuticals Inc. (REGN) American Society of Hematology 2023 Investor Conference - (Transcript) Alvotech: Biosimilars Portfolio Opportunity Is High Risk Alvotech (ALVO) Q3 2023 Earnings Call Transc...

2024-01-02 10:00:00 ET Summary United Therapeutics Corporation calls itself a "Public Benefit" company. The reality, it is a cynical monopolist about to lose its monopoly. If patent trolling fails, their premium to the entrant could collapse. Disclaimer . ...

2023-12-27 13:33:38 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals Inc. (REGN) American Society of Hematology 2023 Investor Conference - (Transcript) Regeneron Pharmaceuticals, Inc. (REGN) Piper Sandler 35th Annual Healthcare Conference (Transcript) R...

2023-12-27 12:29:36 ET More on AbbVie, Johnson & Johnson, etc. Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) AbbVie Vs. GSK: Dual Dominance In Pharma ...

2023-12-26 07:02:44 ET More on BioNTech, Moderna, etc. BioNTech's COVID-19 Success Paves The Way For A Strong Drug Pipeline Pfizer: Buy The Panic Pfizer Is Not Cheap, And The 5.7% Yield Is Not As Safe As You Might Think Citi puts Pfizer on catalyst watch afte...

2023-12-22 09:45:00 ET Regeneron Pharmaceuticals (NASDAQ: REGN) is a growing biotech company that generates a ton of free cash flow. Over the years, it has obtained approval or authorization for 12 medicines. Its strong in-house development has made it one of the larger healthcare s...

TARRYTOWN, N.Y., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) will webcast its presentation at the 42 nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. The presentation is scheduled for 2:15 p.m. Pacific Time (5:15 p.m. Eastern Ti...

2023-12-18 11:11:08 ET Summary The Health Care Select Sector SPDR Fund is a popular ETF that provides exposure to the healthcare sector. XLV has shown consistent performance and has outperformed the SPY ETF over the past decade. The ETF comprises major healthcare industry play...

2023-12-18 09:00:00 ET Summary Alnylam plans to significantly expand its clinical pipeline by the end of 2025, with over 15 new candidates entering the clinic. The company is targeting obesity and type 2 diabetes with liver, adipose, and muscle-directed candidates. Alnylam's n...

2023-12-14 13:56:03 ET Regeneron Pharmaceuticals Inc. (REGN) American Society of Hematology 2023 Investor Conference Call December 14, 2023, 8:30 AM ET Company Participants Ryan Crowe - Vice President, Investor Relations George Yancopoulos - Board Co-Chair, Co-Founde...